We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
VRTX icon
1
Vertex Pharmaceuticals
VRTX
$142B
$142B $558.88 3.5%
REGN icon
2
Regeneron Pharmaceuticals
REGN
$96B
$96B $927.89 13.3%
MRNA icon
3
Moderna
MRNA
$88.5B
$88.5B $221.72 0.47%
ARGX icon
4
argenx
ARGX
$56.1B
$56.1B $892.87 0.55%
ONC icon
5
BeOne Medicines Ltd
ONC
$41.9B
$41.9B $370.33 0.33%
RVMD icon
6
Revolution Medicines
RVMD
$41B
$41B $191.31 0.55%
GMAB icon
7
Genmab
GMAB
$35.1B
$35.1B $57.06 1.01%
RPRX icon
8
Royalty Pharma
RPRX
$29.9B
$29.9B $67.18 1.9%
ROIV icon
9
Roivant Sciences
ROIV
$26.7B
$26.7B $36.91 1.63%
INSM icon
10
Insmed
INSM
$24.7B
$24.7B $112.58 0.89%
INCY icon
11
Incyte
INCY
$24.5B
$24.5B $120.39 3.07%
BNTX icon
12
BioNTech
BNTX
$22.1B
$22.1B $88.17 1.08%
ALNY icon
13
Alnylam Pharmaceuticals
ALNY
$22.1B
$22.1B $165 5.17%
EXEL icon
14
Exelixis
EXEL
$16.9B
$16.9B $69.39 4.82%
ASND icon
15
Ascendis Pharma A/S
ASND
$16.5B
$16.5B $251.27 0.68%
HALO icon
16
Halozyme
HALO
$14.9B
$14.9B $130.91 0.21%
BBIO icon
17
BridgeBio Pharma
BBIO
$14.6B
$14.6B $74.95 5.97%
JAZZ icon
18
Jazz Pharmaceuticals
JAZZ
$14B
$14B $215.98 3.92%
SMMT icon
19
Summit Therapeutics
SMMT
$12.8B
$12.8B $16.03 1.05%
TECH icon
20
Bio-Techne
TECH
$11.4B
$11.4B $72.66 0.07%
BMRN icon
21
BioMarin Pharmaceuticals
BMRN
$11.3B
$11.3B $58.51 1.77%
KYMR icon
22
Kymera Therapeutics
KYMR
$10.8B
$10.8B $126.63 3.29%
TWST icon
23
Twist Bioscience
TWST
$10.1B
$10.1B $152.78 11.9%
MDGL icon
24
Madrigal Pharmaceuticals
MDGL
$9.9B
$9.9B $430.36 0.31%
KRYS icon
25
Krystal Biotech
KRYS
$9.8B
$9.8B $332.29 2.38%
1
2 3 4 5

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.31T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $142B, Regeneron Pharmaceuticals (REGN) at $96B and Moderna (MRNA) at $88.5B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.